Effect of Cilostazol in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty
- 1 April 1997
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 79 (8) , 1097-1099
- https://doi.org/10.1016/s0002-9149(97)00052-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1992
- Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplastyCatheterization and Cardiovascular Diagnosis, 1991
- A new approach for the automated definition of path lines in digitized coronary angiogramsThe International Journal of Cardiovascular Imaging, 1990
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.Circulation, 1985
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984